glp-1 mimic receptor agonists What Is GLP-1 and Why
Description
doi: 10.2337/dc13-1283
Nutrient Density: Ensuring every bite counts even when your appetite is low
July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)
Am J Physiol - Regul Integr Comp Physiol (2016) 310(10):R88595
W., Seeley, R
During your consultation in Pittsburgh, our medical team will review your health history to ensure it's a safe option for you and discuss any potential side effects, which are typically mild if they occur
